BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15157256)

  • 1. West Nile virus in plasma is highly sensitive to methylene blue-light treatment.
    Mohr H; Knüver-Hopf J; Gravemann U; Redecker-Klein A; Müller TH
    Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo.
    Papin JF; Floyd RA; Dittmer DP
    Antiviral Res; 2005 Nov; 68(2):84-7. PubMed ID: 16118025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins.
    Wang D; Bu F; Xu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
    Tobler LH; Bianco C; Glynn SA; Schreiber GB; Dille BJ; Prince HE; Lanciotti RS; Linnen JM; Gallarda J; Shyamala V; Smith D; Kleinman SH; Busch MP;
    Transfusion; 2005 Apr; 45(4):480-6. PubMed ID: 15819666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene blue photoinactivation of RNA viruses.
    Floyd RA; Schneider JE; Dittmer DP
    Antiviral Res; 2004 Mar; 61(3):141-51. PubMed ID: 15168794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sensitive TaqMan RT-PCR assay for detection and quantification of both lineages of West Nile virus RNA.
    Tang Y; Anne Hapip C; Liu B; Fang CT
    J Clin Virol; 2006 Jul; 36(3):177-82. PubMed ID: 16675298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photo-inactivation of viruses in therapeutical plasma.
    Mohr H; Lambrecht B; Schmitt H
    Dev Biol Stand; 1993; 81():177-83. PubMed ID: 8174801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. West Nile virus and blood product safety in Germany.
    Pfleiderer C; Blümel J; Schmidt M; Roth WK; Houfar MK; Eckert J; Chudy M; Menichetti E; Lechner S; Nübling CM
    J Med Virol; 2008 Mar; 80(3):557-63. PubMed ID: 18205233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid inactivation of HIV-1 in single donor preparations of human fresh frozen plasma by methylene blue/light treatment.
    Lambrecht B; Norley SG; Kurth R; Mohr H
    Biologicals; 1994 Sep; 22(3):227-31. PubMed ID: 7811456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
    Ruane PH; Edrich R; Gampp D; Keil SD; Leonard RL; Goodrich RP
    Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas).
    Pock K; Heger A; Janisch S; Svae TE; Römisch J
    Transfus Apher Sci; 2007 Dec; 37(3):223-31. PubMed ID: 18006380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence of West Nile virus infection in Dutch blood donors.
    Koppelman MH; Sjerps MS; de Waal M; Reesink HW; Cuypers HT
    Vox Sang; 2006 Apr; 90(3):166-9. PubMed ID: 16507015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
    Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
    Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of West Nile virus in the Mexican blood supply.
    Sánchez-Guerrero SA; Romero-Estrella S; Rodríguez-Ruiz A; Infante-Ramírez L; Gómez A; Villanueva-Vidales E; García-Torres M; Domínguez AM; Vázquez JA; Calderón ED; Valiente-Banuet L; Linnen JM; Broulik A; Harel W; Marín Y López RA
    Transfusion; 2006 Jan; 46(1):111-7. PubMed ID: 16398739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.
    Rios M; Zhang MJ; Grinev A; Srinivasan K; Daniel S; Wood O; Hewlett IK; Dayton AI
    Transfusion; 2006 Apr; 46(4):659-67. PubMed ID: 16584445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Prow NA; Watterson D; Hall RA; Young PR; Reichenberg S; Sumian C; Faddy HM
    Transfusion; 2016 Sep; 56(9):2278-85. PubMed ID: 27456861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
    Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation.
    Schagen FH; Moor AC; Cheong SC; Cramer SJ; van Ormondt H; van der Eb AJ; Dubbelman TM; Hoeben RC
    Gene Ther; 1999 May; 6(5):873-81. PubMed ID: 10505113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.